Evidence map›Paper›PMID 40286740›Full record

ArticleEcotoxicology and environmental safety2025

Cumulative environmental exposures and metabolic syndrome: A study of heavy metals and volatile organic compounds.

Brooke Scardino, Destyn Dicharry, Akshat Agrawal, Diensn Xing, Md Mostafizur Rahman Bhuiyan, Md Shenuarin Bhuiyan, Oren Rom, Steven A Conrad, John A Vanchiere, A Wayne Orr and 2 more

Abstract read
In one paragraph

Article in Ecotoxicology and environmental safety, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Brooke ScardinoDepartment of Medicine, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA 71103, USA.
Destyn DicharryDepartment of Medicine, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA 71103, USA.
Akshat AgrawalDepartment of Medicine, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA 71103, USA.
Diensn XingDepartment of Medicine, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA 71103, USA.
Md Mostafizur Rahman BhuiyanDepartment of Pediatric Cardiology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
Md Shenuarin BhuiyanDepartment of Pathology and Translational Pathobiology, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA 71103, USA; Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA 71103, USA.
Oren RomDepartment of Pathology and Translational Pathobiology, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA 71103, USA; Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA 71103, USA.
Steven A ConradDepartment of Medicine, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA 71103, USA; Department of Pediatrics, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA 71103, USA.
John A VanchiereDepartment of Pediatrics, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA 71103, USA.
A Wayne OrrDepartment of Pathology and Translational Pathobiology, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA 71103, USA; Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA 71103, USA.
Christopher G KevilDepartment of Pathology and Translational Pathobiology, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA 71103, USA; Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA 71103, USA.
Mohammad Alfrad Nobel BhuiyanDepartment of Medicine, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA 71103, USA; Department of Pathology and Translational Pathobiology, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA 71103, USA. Electronic address: Nobel.Bhuiyan@lsuhs.edu.

Funding

Stress Exacerbates Myocardial Ischemic Injury by Blocking Estrogen's Antidoxidant Protection in the Female HeartP20GM121307 · NIGMS · LOUISIANA STATE UNIV HSC SHREVEPORT · PI Vesna Tesic · 2018 to 2026
$23.6M
Nck Adaptor Proteins in Atherogenic Endothelial ActivationR01HL133497 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI ORR, ANTHONY WAYNE · 2016 to 2024
$3.8M
Matrix Signaling in Endothelial Cell DysfunctionR01HL098435 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI ORR, ANTHONY WAYNE · 2010 to 2020
$3.2M
Sigmar1 in lipid metabolismR01HL145753 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI BHUIYAN, MD. SHENUARIN · 2019 to 2023
$2.6M
EphA2 regulation of atherosclerotic smooth muscle phenotypeR01HL173972 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI Anthony Wayne Orr · 2024 to 2026
$2.1M
Lipidated Amino Acids in Cardiometabolic DiseasesR01DK134011 · NIDDK · LOUISIANA STATE UNIV HSC SHREVEPORT · PI Oren Rom · 2022 to 2026
$2.1M
Novel mitophagy regulatory mechanism in heart failureR01HL172970 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI Md. Shenuarin Bhuiyan · 2024 to 2026
$2.0M
EphA2 signaling in atherosclerotic fibroproliferative remodelingR01HL141155 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI ORR, ANTHONY WAYNE · 2019 to 2022
$1.8M
CSE regulation of vascular remodelingR01HL149264 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI KEVIL, CHRISTOPHER G · 2020 to 2023
$1.7M
Dysregulated Oxalate Metabolism in Cardiometabolic DiseasesR01DK136685 · NIDDK · LOUISIANA STATE UNIV HSC SHREVEPORT · PI Oren Rom · 2023 to 2026
$1.7M
Mechanisms of glycine-based therapy for atherosclerosisR00HL150233 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI ROM, OREN SHALOM · 2021 to 2023
$747k
Sigma-1 receptor and cardioprotectionR00HL122354 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI BHUIYAN, MD. SHENUARIN · 2015 to 2017
$747k
NHLBI NIH HHS R00 HL122354NHLBI NIH HHS R00 HL150233NHLBI NIH HHS R01 HL098435NHLBI NIH HHS R01 HL133497NHLBI NIH HHS R01 HL141155NHLBI NIH HHS R01 HL145753NHLBI NIH HHS R01 HL149264NHLBI NIH HHS R01 HL172970NHLBI NIH HHS R01 HL173972NIDDK NIH HHS R01 DK134011NIDDK NIH HHS R01 DK136685NIGMS NIH HHS P20 GM121307
6 · The paper itself

Abstract

backgroundMetabolic Syndrome (MetS), a condition affecting over one-third of the U.S. population, heightens the risk of cardiovascular disease, Type 2 diabetes, and premature mortality. While individual links between heavy metals (HM), volatile organic compounds (VOC), and MetS have been established, the impact when these environmental toxins are combined remains unclear and unexplored. This study investigates how simultaneous exposure to HMs and VOCs influences the risk of MetS.

methodsWeighted Quantile Sum regression and Bayesian kernel Machine Regression were performed on data from 6603 participants in the National Health and Nutrition Examination Survey (2011-2020) to determine the impact of HMs and VOCs detected in urine on MetS. Further analyses were performed for individuals placed in subgroups based on age, sex, race/ethnicity, and monthly poverty level index.

resultsThe analyses reveal that combined exposure to HMs and VOCs is associated with an increased risk of MetS; in particular, exposure to cadmium, tin, N-acetyl-S-(N-methyl carbamoyl)-L-cysteine, and N-acetyl-S-(2-carboxyethyl)-L-cysteine significantly elevates the risk of developing MetS. Younger adults (18-50 years), men, Hispanics and non-Hispanic whites, and those with a monthly poverty index > 1.3 (higher socioeconomic status) emerged as the most vulnerable groups.

conclusionThese findings emphasize an urgent need to address and tackle the cumulative impact of environmental toxins through a shift in public health efforts to go beyond investigating isolated exposures to address real-world chemical exposures. By understanding these cumulative risks, we can begin to mitigate them and pave the way for more effective interventions, especially for at-risk populations.

Indexed as

Environmental ExposureMetabolic SyndromeMetals, HeavyVolatile Organic CompoundsAdolescentAdultFemaleHumansMaleMiddle AgedNutrition SurveysUnited StatesYoung AdultMetals, HeavyVolatile Organic CompoundsHeavy metalsMetabolic syndromeVolatile organic compounds

Identifiers

PMID40286740
PMCPMC12291170

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.